These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Aminosalicylates in the treatment of chronic inflammatory bowel diseases]. Hartmann F; Plauth M Internist (Berl); 1990 Nov; 31(11):702-6. PubMed ID: 2289856 [No Abstract] [Full Text] [Related]
8. Current medical therapy for inflammatory bowel disease. Bonner GF South Med J; 1996 Jun; 89(6):556-66. PubMed ID: 8638193 [TBL] [Abstract][Full Text] [Related]
9. [Changing treatment of inflammatory bowel diseases]. Karvonen AL; Matikainen M; Turunen U Duodecim; 1994; 110(20):1945-54. PubMed ID: 7555809 [No Abstract] [Full Text] [Related]
16. Aminosalicylates in the treatment of inflammatory bowel disease. Sutherland LR Inflamm Bowel Dis; 1998 May; 4(2):113. PubMed ID: 9687217 [No Abstract] [Full Text] [Related]
17. Folliculitis and mesalamine. Lizasoain J; Rubio FA; Erdozain JC; Olveira A; Conde P Am J Gastroenterol; 1996 Apr; 91(4):819-20. PubMed ID: 8677969 [No Abstract] [Full Text] [Related]
18. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity]. Loizeau E Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252 [No Abstract] [Full Text] [Related]
19. [Inflammatory bowel disease. Should aminosalicylates be administered in a single daily dose in ulcerative colitis?]. Sicilia Aladrén B Gastroenterol Hepatol; 2008; 31(6):396-7. PubMed ID: 18570819 [No Abstract] [Full Text] [Related]
20. 5-Aminosalicylic acid, 1,000-mg caplets versus 500-mg tablets, in maintenance of remission in ulcerative colitis. Odes HS J Clin Gastroenterol; 1997 Jun; 24(4):287-8. PubMed ID: 9252863 [No Abstract] [Full Text] [Related] [Next] [New Search]